NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: Bruker Corporation
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Bruker Launches Second-Generation FluoroType® SARS-CoV-2 plus PCR Test for Detection of SARS-CoV-2 Viral Infections in Europe - Bruker Corporation announced the launch of the FluoroType® SARS-CoV-2 plus next-generation 6-plex PCR assay for the highly specific detection of the SARS-CoV-2 virus, which causes the respiratory and systemic disease COVID-19 (CV19) - Hain-LifeScience.de
Bruker Launches Second-Generation FluoroType® SARS-CoV-2 plus PCR Test for Detection of SARS-CoV-2 Viral Infections in Europe

 

NewswireToday - /newswire/ - Nehren, Rhineland-Palatinate, Germany, 2020/07/27 - Bruker Corporation announced the launch of the FluoroType® SARS-CoV-2 plus next-generation 6-plex PCR assay for the highly specific detection of the SARS-CoV-2 virus, which causes the respiratory and systemic disease COVID-19 (CV19) - Hain-LifeScience.de . NASDAQ: BRKR

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

• Detects two independent SARS-CoV-2 viral RNA targets from respiratory samples for increased confidence;
• Differentiates SARS-CoV-2 from four other endemic human coronaviruses for specificity;
• Validated with Bruker-Hain GenoXtract® NA and GenoXtract® 96 X3 nucleic acid extraction system and kits;
• Validated with novel Bruker-Hain FluoroCycler® XT real-time PCR thermocycler.

The FluoroType® SARS-CoV-2 plus assay is CE-IVD labelled according to the European IVD Directive (98/79/EC). In two clinical trials involving approximately ninety CV19 positive patients and over 100 CV19 negative individuals, this advanced CV19 infection assay showed 100% sensitivity and 100% specificity. Actual clinical results may be lower, as all PCR tests depend on properly timed and executed nasopharyngeal or oropharyngeal sampling.

The FluoroType® SARS-CoV-2 plus assay has been validated for respiratory samples (nasopharyngeal swabs and oropharyngeal swabs in viral transport medium) using commonly available laboratory real-time PCR thermocyclers. The kit includes all necessary reagents to produce up to 96 results in under two hours. It is validated for use on Bruker's GenoXtract® (GXT) automated nucleic acid extraction devices with associated extraction kits. The FluoroType® SARS-CoV-2 plus assay can also be used with Bruker's novel, high-precision FluoroCycler® XT real-time PCR system or alternatively with other commonly available real-time thermocyclers. The assay targets two independent genes of the SARS-CoV-2 genome, while simultaneously allowing for the differentiation of non-SARS-CoV-2 patients by detecting four endemic human coronaviruses (HCoVs) using four different HCoV gene locations.

Dr. Steffi Czieschnek, the Head of PCR Diagnostics at Medical Health Care Center (MVZ) for Clinical Chemistry and Microbiology in Suhl, Germany, explained: "We have implemented Bruker's FluoroType® SARS-CoV-2 plus assay since several weeks now as our standard routine approach for COVID-19 testing. We like the added value of a second gene target and of the discrimination of potential other human coronaviruses. We use this second generation COVID-19 assay on the FluoroCycler® XT and are impressed by the capabilities and performance of this new cutting-edge real-time PCR platform."

Dr. Wolfgang Pusch, Executive Vice President Microbiology & Diagnostics at Bruker Daltonics, commented: "With the combination of our GenoXtract® (GXT) products for nucleic acid extraction, our latest FluoroCycler® XT real-time thermocycler and dedicated detection assays, Bruker offers a complete solution for the sample preparation and detection of the SARS-CoV-2 virus. With the FluoroType® SARS-CoV-2 plus assay we expand our portfolio by an assay with added value by detecting two gene targets. Additionally, the differentiation from other human coronaviruses, which for example can cause a common cold, reduces the risk of false positive results due to potential cross-reactivity. We expect that these analytical features enable a very robust second-generation PCR assay with highest sensitivity and specificity."

In a pilot phase and in collaboration with several partners, Bruker has recently also begun to offer CE-IVD marked serology antibody tests to detect previous COVID-19 infection in selected European countries, as well as a CE-IVD point-of-care (POC) antigen tests to screen for active CV19 infections in under two hours.

About Bruker-Hain Diagnostics

Bruker-Hain Diagnostics (hain-lifescience.de) is focused on Molecular Diagnostics (MDx) products within Bruker's Microbiology & Diagnostics business. Hain Lifescience GmbH is the legal manufacturer of the FluoroCycler® XT, MTBDR 2.0 assay, GXT nucleic acid preparation kits and of the FluoroType SARS-CoV-2 plus assays.

About Bruker Corporation

Bruker (bruker.com) is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology.

Investor Contact: Miroslava Minkova - Director, Investor Relations & Corporate Development
T: +1 978-663-3660 x1479 - E: investor.relations[.]bruker.com.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services / Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Bruker Corporation

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services / Equipment articles,
CATCH Visitors via Your Competitors Announcements!


Bruker Launches Second-Generation FluoroType® SARS-CoV-2 plus PCR Test for Detection of SARS-CoV-2 Viral Infections in Europe

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Philip Perry - Bruker Daltonics 
+49 172-313-7216 philip.perry[.]bruker.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Bruker Corporation securities in any jurisdiction including any other companies listed or named in this release.

Medical Services / Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Bruker Corporation / Company Profile


Read Medical Services / Equipment Most Recent Related Newswires:

ENvizion Medical Ltd Applauded by Frost & Sullivan for its Innovation in the Enteral Feeding Tube Navigation Industry
Eurosets Lauded by Frost & Sullivan for its Integrated ECLS System, ECMOLife
Laboratorios Inibsa Selects TrackWise Digital to Accelerate its Digital Quality Journey
Bruker Enters Partnership with Cambridge Isotope Laboratories to Further Strengthen LabScape® Portfolio of NMR Solutions
PathogenDx Applauded by Frost & Sullivan for its Ultra-rapid COVID-19 Testing Platform, DetectX-Rv Test
Tripp Lite Introduces New Hospital-Grade UV Charging Stations
Gentex Applauded by Frost & Sullivan for its Comprehensive Powered Air Purifying Respiratory Solution Suite PureFlo 3000
Cardiology Prepared for the Fourth Dimension
Withings Health Solutions Launches Cellular Devices to Eliminate Telehealth Pain Points for Healthcare Professionals and Patients
ScImage Lauded by Frost & Sullivan for its Cloud-based Enterprise Imaging Platform, PICOM365
RapidAI Acclaimed by Frost & Sullivan for its AI-powered Modular Stroke Platform
Belgian Initiative for AI Lung Scan Analysis in Fight Against COVID-19 Goes European
EyeQue Acclaimed by Frost & Sullivan for its Wide Range of Consumer-friendly, Hand-held Ophthalmic Monitoring Solutions
Withings Joins Decentralized Trials & Research Alliance (DTRA) to Democratize and Accelerate Clinical Trials
RapidAI Receives 2020 Global Company of the Year Award from Frost & Sullivan for its AI-Powered Stroke Imaging and Diagnosis Technologies

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  BizJobs.com





 
  ©2021 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)